Portfolio company
Eradivir
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Enanta
This biotechnology company develops small molecule medicines to treat viral infections and immunological diseases for patients with serious medical conditions.
Stratosvir
This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
Redona Therapeutics
This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.
Apini Therapeutics
This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.
EXO Therapeutics
This biotechnology company develops small-molecule drugs targeting enzyme exosites for healthcare institutions and pharmaceutical partners to treat oncology and inflammatory diseases.
Halo Therapeutics
This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.
Enodia
This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.
